Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Duewell

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Oncoimmunology|May 6, 2015
Induction of immunogenic cell death by targeting RIG-I-like helicases in pancreatic cancerMax Schnurr, Peter Duewell
Seminars in Immunology|October 1, 2018
NLRP3 inflammasome activation in inflammagingEicke Latz, Peter Duewell
Oncoimmunology|June 14, 2013
Breaking tumor-induced immunosuppression with 5'-triphosphate siRNA silencing TGFβ and activating RIG-IMax Schnurr, Peter Duewell
Methods in Molecular Biology (Clifton, N.J.)|July 16, 2013
Assessment and quantification of crystal-induced lysosomal damagePeter Duewell, Eicke Latz
Current Opinion in Immunology|March 17, 2026
Immune dyshomeostasis in lifestyle-associated diseases: a new paradigm for personalized medicine and preventionPeter Duewell, Andreas Diefenbach, Eicke Latz
Digestive Diseases (Basel, Switzerland)|October 19, 2012
Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factorsChristian Bauer, Peter Duewell, Hans-Anton Lehr, et al.
Deutsches Arzteblatt International|December 16, 2015
Immunotherapy in TumorsSebastian Kobold, Peter Duewell, Max Schnurr, et al.
Cancer Letters|March 13, 2016
Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancerChristian Bauer, Benjamin Kühnemuth, Peter Duewell, et al.
Immunotherapy|April 29, 2015
Strategies to relieve immunosuppression in pancreatic cancerMax Schnurr, Peter Duewell, Christian Bauer, et al.
Nature Communications|November 9, 2019
Homogentisic acid-derived pigment as a biocompatible label for optoacoustic imaging of macrophagesIna Weidenfeld, Christian Zakian, Peter Duewell, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Oncoimmunology|May 6, 2015
Induction of immunogenic cell death by targeting RIG-I-like helicases in pancreatic cancerMax Schnurr, Peter Duewell
Seminars in Immunology|October 1, 2018
NLRP3 inflammasome activation in inflammagingEicke Latz, Peter Duewell
Oncoimmunology|June 14, 2013
Breaking tumor-induced immunosuppression with 5'-triphosphate siRNA silencing TGFβ and activating RIG-IMax Schnurr, Peter Duewell
Methods in Molecular Biology (Clifton, N.J.)|July 16, 2013
Assessment and quantification of crystal-induced lysosomal damagePeter Duewell, Eicke Latz
Current Opinion in Immunology|March 17, 2026
Immune dyshomeostasis in lifestyle-associated diseases: a new paradigm for personalized medicine and preventionPeter Duewell, Andreas Diefenbach, Eicke Latz
Digestive Diseases (Basel, Switzerland)|October 19, 2012
Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factorsChristian Bauer, Peter Duewell, Hans-Anton Lehr, et al.
Deutsches Arzteblatt International|December 16, 2015
Immunotherapy in TumorsSebastian Kobold, Peter Duewell, Max Schnurr, et al.
Cancer Letters|March 13, 2016
Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancerChristian Bauer, Benjamin Kühnemuth, Peter Duewell, et al.
Immunotherapy|April 29, 2015
Strategies to relieve immunosuppression in pancreatic cancerMax Schnurr, Peter Duewell, Christian Bauer, et al.
Nature Communications|November 9, 2019
Homogentisic acid-derived pigment as a biocompatible label for optoacoustic imaging of macrophagesIna Weidenfeld, Christian Zakian, Peter Duewell, et al.
Pageof 4